Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomised Controlled Trial Comparing Efficacy of Single Versus Multiple Intravitreal Anti-VEGF Injections to Prevent Diabetic Retinopathy Progression in Patients Undergoing Cataract Surgery

NCT07301775 is registered in ClinicalTrials.gov with Ahmad Zeeshan Jamil as lead sponsor.

NCT NCT07301775
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07301775 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomised Controlled Trial Comparing Efficacy of Single Versus Multiple Intravitreal Anti-VEGF Injections to Prevent Diabetic Retinopathy Progression in Patients Undergoing Cataract Surgery
Lead sponsor
Ahmad Zeeshan Jamil
Phase
Phase 4
Overall status
Not yet recruiting
Start date
January 1, 2026
Completion date
September 30, 2026
Enrollment
166 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cataract, diabetic macular edema (dme), diabetic retinopathy (dr), intravitreal injection, phacoemulfisication+iol implantation